TGF-β signaling regulates SPOP expression and promotes prostate cancer cell stemness

Aging (Albany NY). 2020 May 1;12(9):7747-7760. doi: 10.18632/aging.103085. Epub 2020 May 1.

Abstract

SPOP, a substrate binding adaptor of E3 ubiquitin ligase Cullin3, is frequently mutated in human prostate cancer (PCa). However, whether and how SPOP is regulated at transcriptional level in PCa remain unclear. Here, we report that SPOP is down-regulated in PCa stem-like cells (CSCs) and tissues. Our study reveals that SPOP expression is repressed by TGF-β / SMAD signaling axis in PCa CSCs. SPOP promoter contains SMAD-binding elements (SBEs), which can interact with SMAD3. Moreover, TGF-β signaling inhibitor SB431542 promotes the SPOP expression and abrogates PCa stemness. Clinically, SPOP expression is downregulated in PCa patients, which is significantly related to a poor prognosis and lower survival rate. Thus, our findings uncover a mechanism of how SPOP expression is mediated in PCa CSCs via TGF-β/ SMAD3 signaling.

Keywords: SMAD3; SPOP; TGF-β signaling; prostate cancer; stemness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Down-Regulation*
  • Humans
  • Male
  • Nuclear Proteins / biosynthesis
  • Nuclear Proteins / genetics*
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology
  • Protein Binding
  • RNA, Neoplasm
  • Repressor Proteins / biosynthesis
  • Repressor Proteins / genetics*
  • Transforming Growth Factor beta / genetics*
  • Transforming Growth Factor beta / metabolism

Substances

  • Nuclear Proteins
  • RNA, Neoplasm
  • Repressor Proteins
  • SPOP protein, human
  • Transforming Growth Factor beta